Palbociclib

Palbociclib
Product Description

Palbociclib is an oral, selective inhibitor of cyclin-dependent kinases 4 and 6, designed to reduce tumour-cell proliferation by controlling cell-cycle progression. It is available as 75 mg, 100 mg and 125 mg tablets in packs of 7 or 21, supporting treatment cycles and individualized dose modification.Expected Marketing Authorization: Q1 2028.

Ilko Ilac Sanayi ve Ticaret A.S

  • Country/Region:
    Türkiye
  • Founded:
    2012
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical
OTC
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Therapeutic Area: OncologyTherapeutic Class: Antineoplastic Agent – CDK4/6 Inhibitor 
    Active Ingredient: Palbociclib 
    Application Areas: Used in combination with endocrine therapy for the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, subject to approved local prescribing information.
  • Selling Points
    Brand Name; Ethical Sourcing; Experienced Technicians; Guarantee/Warranty; Three strength options—75 mg, 100 mg and 125 mg—to support individualized dosing and dose reduction when required. Pack sizes of 7 and 21 tablets are aligned with treatment-cycle requirements. Expected Marketing Authorization: Q1 2028.
  • Model
    Tablet
  • Supplied from
    Türkiye
  • Measured In
    milligram

Ilko Ilac Sanayi ve Ticaret A.S

  • Country/Region:
    Türkiye
  • Founded:
    2012
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical
OTC
Pharmaceutical Company (generic finished products)

More Products from Ilko Ilac Sanayi ve Ticaret A.S (99)

  • Tricef- Cefdinir

    Product Tricef- Cefdinir

    Cefdinir is an oral third-generation cephalosporin antibiotic used in the treatment of susceptible bacterial infections. It acts by inhibiting bacterial cell wall synthesis, resulting in bactericidal activity against susceptible organisms. The portfolio includes 300 mg film-coated tablets in packs of 10 an...
  • Cefdia- Cefixime

    Product Cefdia- Cefixime

    Cefixime is an oral third-generation cephalosporin antibiotic used in the treatment of susceptible bacterial infections. It exerts bactericidal activity by inhibiting bacterial cell wall synthesis. The product is available as 400 mg film-coated tablets in packs of 5 and 10 tablets, providing oral antibioti...
  • Fortevir- Entecavir

    Product Fortevir- Entecavir

    Entecavir is an antiviral agent used in the treatment of chronic hepatitis B virus (HBV) infection. It is a guanosine nucleoside analogue that inhibits HBV DNA polymerase, thereby reducing viral replication. The product is available in 0.5 mg and 1 mg film-coated tablet strengths, each supplied in packs of...
  • Fluson- Oseltamivir

    Product Fluson- Oseltamivir

    Oseltamivir is an antiviral agent used for the treatment and prevention of influenza. It is a neuraminidase inhibitor that blocks the influenza virus neuraminidase enzyme, thereby limiting the release and spread of newly formed viral particles. The product is available as 75 mg capsules in packs of 10 caps...
  • Hiverac- Tenofovir Disoproxil Fumarate

    Product Hiverac- Tenofovir Disoproxil Fumarate

    Tenofovir Disoproxil Fumarate is an antiviral agent used in the treatment of human immunodeficiency virus (HIV) infection and chronic hepatitis B virus (HBV) infection. It is a nucleotide reverse transcriptase inhibitor that is converted in the body to tenofovir, which inhibits viral reverse transcriptase ...
  • Hivent- Tenofovir Disoproxil Fumarate / Emtricitabine

    Product Hivent- Tenofovir Disoproxil Fumarate / Emtricitabine

    Tenofovir Disoproxil Fumarate / Emtricitabine is a fixed-dose antiviral combination used in the management of human immunodeficiency virus (HIV) infection and, where approved, for HIV pre-exposure prophylaxis. Tenofovir disoproxil fumarate and emtricitabine are nucleotide/nucleoside reverse transcriptase i...
  • Dasatinib

    Product Dasatinib

    Dasatinib is an oral tyrosine kinase inhibitor targeting BCR-ABL and other relevant kinases involved in malignant cell proliferation. It is available as 20 mg, 50 mg and 70 mg film-coated tablets in packs of 60, and as 100 mg and 140 mg film-coated tablets in packs of 30. The broad strength range supports ...
  • Ruxolitinib

    Product Ruxolitinib

    Ruxolitinib is an oral Janus kinase 1 and 2 inhibitor developed to modulate abnormal JAK-STAT signalling associated with selected haematological disorders. It is available as 5 mg, 10 mg, 15 mg and 20 mg tablets in multiple pack sizes, including 14, 56 and 168 tablets depending on the strength, supporting ...
  • Erlotinib

    Product Erlotinib

    Erlotinib is an oral epidermal growth factor receptor tyrosine kinase inhibitor that helps inhibit signalling pathways associated with tumour-cell proliferation and survival. It is available as 100 mg and 150 mg tablets in packs of 30, providing strength options for standard treatment and dose adjustment r...
  • Sorafenib

    Product Sorafenib

    Sorafenib is an oral multikinase inhibitor targeting signalling pathways involved in tumour-cell proliferation and tumour angiogenesis. It is available as 200 mg film-coated tablets in packs of 112, designed to support the established dosing schedule used in eligible oncology patients.  Expected ...
  • Grafta-Anagrelide Hydrochloride

    Product Grafta-Anagrelide Hydrochloride

    Anagrelide Hydrochloride is an oral platelet-lowering agent used in the management of elevated platelet counts associated with essential thrombocythaemia and other myeloproliferative disorders. It acts primarily by inhibiting megakaryocyte maturation and reducing platelet production. The product is availab...
  • Jandark - Tofacitinib Citrate

    Product Jandark - Tofacitinib Citrate

    Tofacitinib Citrate is an oral immunosuppressive and immunomodulatory agent used in the management of selected chronic inflammatory and autoimmune diseases. It belongs to the Janus kinase (JAK) inhibitor class and modulates intracellular signaling pathways involved in immune and inflammatory responses. The...

Ilko Ilac Sanayi ve Ticaret A.S resources (2)